In China, MAPT gene mutations represent a predominant pathogenic factor for FTD, underscoring the clinical significance of understanding genotype-phenotype correlations for diagnosis and management (Jiang et al., 2021). This evidence concerns the gene MAPT and frontotemporal dementia.